Max Healthcare Reports Q4FY26 Results; Profit Jumps 7.3% YoY, Announces Rs 2 Per Share Dividend
DSIJ Intelligence / 21 May 2026 / Categories: Mindshare, Quarterly Results, Trending
Max Healthcare reported FY26 revenue of Rs 8,373 crore and profit of Rs 1,442 crore, while Q4FY26 profit for the period rose to Rs 342 crore.
On Thursday, the Indian equity benchmarks ended marginally lower, with the benchmark Nifty 50 index settling near the 23,655 mark. Healthcare stocks remained in focus following quarterly earnings announcements. In this segment, Max Healthcare's share price ended higher by 1.43 per cent at Rs 1,091.10 after the company announced its Q4FY26 and FY26 consolidated financial results.
Max Healthcare Q4FY26 Results
Max Healthcare Institute reported consolidated total income of Rs 2,190.72 crore during Q4FY26 as against Rs 1,956.66 crore reported in Q4FY25, registering a growth of around 11.9 per cent YoY.
Profit for the period stood at Rs 342.22 crore in Q4FY26 compared to Rs 319.00 crore reported in the corresponding quarter of the previous year, reflecting a growth of around 7.3 per cent YoY.
Profit before Tax for the quarter came in at Rs 464.58 crore as against Rs 402.50 crore reported in Q4FY25. Total comprehensive income for the quarter stood at Rs 343.47 crore compared to Rs 318.87 crore reported in the corresponding quarter previous year.
Max Healthcare FY26 Performance
For the financial year ended March 31, 2026, Max Healthcare Institute reported consolidated revenue from operations of Rs 8,373.45 crore as against Rs 7,028.46 crore reported in FY25, registering a growth of around 19.1 per cent YoY.
Profit for the year stood at Rs 1,442.41 crore during FY26 compared to Rs 1,075.88 crore reported in FY25, reflecting a growth of around 34.1 per cent YoY.
The company’s basic earnings per share stood at Rs 14.83 during FY26 compared to Rs 11.07 reported in FY25.
Dividend Announcement
The Board of Directors recommended a final dividend of Rs 2 per equity share, representing 20 per cent of the face value of Rs 10 each, for the financial year 2025-26, subject to shareholders’ approval at the ensuing Annual General Meeting.
Expansion Update
The company approved the Construction of Phase-I of Max Super Specialty Hospital at Shaheed Path, Lucknow, with a proposed capacity addition of around 712 beds. The project is expected to involve an investment of around Rs 1,400 crore and will be funded through a mix of debt and internal accruals.
About Max Healthcare Institute
Max Healthcare Institute Ltd is one of India’s leading healthcare service providers operating hospitals, medical centres and diagnostic facilities across multiple cities. The company primarily operates in the medical and healthcare services segment and manages a large network of multi-speciality and super-speciality hospitals across India.
Add DSIJ as your preferred news source on G o o g l e
Add NowWhat are your views on Max Healthcare Institute’s Q4FY26 performance and expansion plans in the healthcare segment? Share your thoughts in the comments below.
Disclaimer: This article is for informational purposes only and not investment advice.